ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1

Historical Holders from Q3 2023 to Q1 2025

CUSIP
02043QAB3
Type / Class
Debt / NOTE 1.000% 9/1
All holders as of December 31, 2024
Q4 2024
Principal, excl. options
922M
Holdings value
$983M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
66
Number of buys
24
Number of sells
-29
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1

Period Principal Value Change Price Investors
2025 Q1 $2.64M $2.88M $1.15 3
2024 Q4 $922M $983M +$11M $1.07 66
2024 Q3 $904M $1.06B -$27.9M $1.17 57
2024 Q2 $905M $978M -$105M $1.08 64
2024 Q1 $1.01B $956M +$33.1M $0.94 69
2023 Q4 $870M $847M +$31.5M $0.99 65
2023 Q3 $847M $810M +$707M $0.93 54